Trials / Unknown
UnknownNCT01986140
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Julie Nangia · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine that the Orbis Paxman Hair Loss Prevention System is safe and effective in reducing chemotherapy-induced alopecia in woman with breast cancer undergoing neoadjuvant or adjuvant chemotherapy.
Detailed description
Cooling the scalp during chemotherapy may help reduce the chances of losing hair during treatment. The investigators are hoping that using the PAXMAN Orbis Scalp Cooling Device may stop patients who are undergoing chemotherapy from losing their hair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PAXMAN Orbis Scalp Cooler | Treatment with Orbis scalp cooling cap |
| OTHER | Control No treatment | No treatment to prevent hair loss |
Timeline
- Start date
- 2014-05-15
- Primary completion
- 2017-02-10
- Completion
- 2022-12-01
- First posted
- 2013-11-18
- Last updated
- 2021-07-27
- Results posted
- 2018-10-16
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01986140. Inclusion in this directory is not an endorsement.